# The Effects of Oxytocin in Obese Adults

> **NCT03043053** · PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 61 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** oxytocin nasal spray
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03043053
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-01
- **Primary completion:** 2022-05-20
- **Final completion:** 2022-07-07
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03043053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03043053, "The Effects of Oxytocin in Obese Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03043053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*